| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹1000 |
| Expense Ratio | 1.23% |
| NAV | ₹288.91 (23 Oct 2020) |
|---|---|
| Fund Started | 01 Jan 2013 |
| Fund Size | ₹2,316 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Coromandel International Ltd. | Chemicals | Equity | 4.7% |
| Mphasis Ltd. | Technology | Equity | 4.3% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 3.1% |
| Sanofi India Ltd. | Healthcare | Equity | 2.9% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 2.9% |
| Cadila Healthcare Ltd. | Healthcare | Equity | 2.7% |
| KEC International Ltd. | Engineering | Equity | 2.6% |
| Torrent Power Ltd. | Energy | Equity | 2.6% |
| Cholamandalam Financial Holdings Ltd. | Financial | Equity | 2.5% |
| Max Financial Services Ltd. | Financial | Equity | 2.4% |
Aditya Birla Sun Life Mid Cap Direct Fund Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 01 Jan 2013. Jayesh Gandhi is the Current Fund Manager of Aditya Birla Sun Life Mid Cap Direct Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹2,316 Cr and the Latest NAV as of 23 Oct 2020 is ₹288.91.
The Aditya Birla Sun Life Mid Cap Direct Fund Growth is rated Moderately High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 1000. Exit load of 1% if redeemed within 365 days.
The scheme aims at long-term growth of capital at controlled level of risk by investing primarily in mid-cap stocks, to generate returns higher than a fund focused on large and liquid stocks. A small portion of the portfolio may be kept in call & money market instruments in order to meet the liquidity needs.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.